City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  David Snyder, MD  
Search results:  3  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-3 Trials Jump to page:

COH Protocol Number: 14042 ClinicalTrials.gov Number: NCT02055781

Principal Investigator: David Snyder, MD
Sponsor: Industrial

Title:  A Randomized Controlled Phase 3 Study of Oral Pacritinib versus Best Available Therapy in Patients with Thrombocytopenia and Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

COH Protocol Number: 13239 ClinicalTrials.gov Number: NCT01850004

Principal Investigator: David Snyder, MD
Sponsor: Industrial

Title:  Open-Label Single Arm Phase 2 Study Evaluating Dasatinib Therapy Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia (CP-CML) with Stable Complete Molecular Response (CMR) DASFREE

COH Protocol Number: 13151 ClinicalTrials.gov Number: NCT01744665

Principal Investigator: David Snyder, MD
Sponsor: Industrial

Title:  A Phase II Randomized, Multicenter Study of Treatment-Free Remission in Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Patients who Achieve and Sustain MR4.5 after Switching to Nilotinib

 
Results per page: 25 50 100 All 1-3 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.